Rochester Institute of Technology hosts AI and Data Science Summit with Vellore Institute of Technology in Chennai: Our ...
Quanta receives US FDA clearance to begin phase 1 trial of QTX3544, an oral G12V-preferring, dual ON/OFF state, multi-KRAS inhibitor: Radnor, Pennsylvania Friday, January 10, 2025 ...
Sanofi announces new Sarclisa subcutaneous formulation meets co-primary endpoints in IRAKLIA phase 3 study in multiple myeloma: Paris Friday, January 10, 2025, 15:00 Hrs [IST] Res ...
Biocon Biologics to present at the 43rd annual J P Morgan Healthcare Conference: Our Bureau, Bengaluru Friday, January 10, 2025, 15:10 Hrs [IST] Biocon Biologics, a fully integrat ...